279 related articles for article (PubMed ID: 34965582)
1. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
2. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
Wang S; Sun Q; Xu Y; Pei J; Lai L
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion.
Tian X; Shen L; Gao P; Huang L; Liu G; Zhou L; Peng L
Front Microbiol; 2022; 13():740382. PubMed ID: 35295301
[TBL] [Abstract][Full Text] [Related]
4. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
[TBL] [Abstract][Full Text] [Related]
5. Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
Zhou L; Wang J; Liu G; Lu Q; Dong R; Tian G; Yang J; Peng L
Genomics; 2020 Nov; 112(6):4427-4434. PubMed ID: 32745502
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures.
Peng L; Shen L; Xu J; Tian X; Liu F; Wang J; Tian G; Yang J; Zhou L
Sci Rep; 2021 Mar; 11(1):6248. PubMed ID: 33737523
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing against SARS-CoV-2 using computational approaches.
Kumar S; Kovalenko S; Bhardwaj S; Sethi A; Gorobets NY; Desenko SM; Poonam ; Rathi B
Drug Discov Today; 2022 Jul; 27(7):2015-2027. PubMed ID: 35151891
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model.
Hu F; Jiang J; Yin P
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009050
[TBL] [Abstract][Full Text] [Related]
9. Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization.
Wang Y; Xiang J; Liu C; Tang M; Hou R; Bao M; Tian G; He J; He B
Front Microbiol; 2022; 13():1062281. PubMed ID: 36545200
[TBL] [Abstract][Full Text] [Related]
10. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
Verma AK; Aggarwal R
Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
[TBL] [Abstract][Full Text] [Related]
11. A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
Yao Y; Zhang Y; Li Z; Chen Z; Wang X; Li Z; Yu L; Cheng X; Li W; Jiang WJ; Wu HJ; Feng Z; Sun J; Fei T
Biochem Biophys Res Commun; 2023 Oct; 675():113-121. PubMed ID: 37467664
[TBL] [Abstract][Full Text] [Related]
12. Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning.
Azmoodeh SK; Tsigelny IF; Kouznetsova VL
Front Biosci (Landmark Ed); 2022 Apr; 27(4):113. PubMed ID: 35468672
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new drug indications for COVID-19: A drug repurposing approach.
Kumari P; Pradhan B; Koromina M; Patrinos GP; Steen KV
PLoS One; 2022; 17(5):e0267095. PubMed ID: 35609015
[TBL] [Abstract][Full Text] [Related]
14. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
Zeng X; Song X; Ma T; Pan X; Zhou Y; Hou Y; Zhang Z; Li K; Karypis G; Cheng F
J Proteome Res; 2020 Nov; 19(11):4624-4636. PubMed ID: 32654489
[TBL] [Abstract][Full Text] [Related]
15. Computational drug repurposing study of the RNA binding domain of SARS-CoV-2 nucleocapsid protein with antiviral agents.
Tatar G; Ozyurt E; Turhan K
Biotechnol Prog; 2021 Mar; 37(2):e3110. PubMed ID: 33314794
[TBL] [Abstract][Full Text] [Related]
16. A deep learning framework for predicting molecular property based on multi-type features fusion.
Ma M; Lei X
Comput Biol Med; 2024 Feb; 169():107911. PubMed ID: 38160501
[TBL] [Abstract][Full Text] [Related]
17. Weighted hypergraph learning and adaptive inductive matrix completion for SARS-CoV-2 drug repositioning.
Ma Y; Zhong J; Zhu N
Methods; 2023 Nov; 219():102-110. PubMed ID: 37804962
[TBL] [Abstract][Full Text] [Related]
18. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
19. In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking.
Cavasotto CN; Di Filippo JI
Mol Inform; 2021 Jan; 40(1):e2000115. PubMed ID: 32722864
[TBL] [Abstract][Full Text] [Related]
20. Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction.
Peng L; Tian X; Shen L; Kuang M; Li T; Tian G; Yang J; Zhou L
Front Genet; 2020; 11():577387. PubMed ID: 33193695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
